About Golgi-associated kinase 1B
Golgi-associated kinase 1B (GASK1B) is a protein
from Homo sapiens identified by UniProt accession
Q6UWH4, 519 residues long.
MolForge cross-references it against 0 known binders and
40 disease associations.
Target properties
| Protein name | Golgi-associated kinase 1B |
| UniProt accession | Q6UWH4 |
| Gene | GASK1B |
| Organism | Homo sapiens |
| Length | 519 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (40)
Diseases linked to this target (Open Targets).
- reticulocyte count · score 0.31
- reticulocyte measurement · score 0.23
- self reported educational attainment · score 0.18
- chronotype measurement · score 0.06
- pulse pressure measurement · score 0.03
- blood protein measurement · score 0.03
- neoplasm · score 0.03
- in situ carcinoma · score 0.03
- cancer · score 0.02
- clear cell renal carcinoma · score 0.02
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q6UWH4-F1 | alphafold | PREDICTED | 71.65 | — |
Amino-acid sequence (519 residues)
MTCPDKPGQL INWFICSLCV PRVRKLWSSR RPRTRRNLLL GTACAIYLGF LVSQVGRASL QHGQAAEKGP HRSRDTAEPS FPEIPLDGTL APPESQGNGS TLQPNVVYIT LRSKRSKPAN IRGTVKPKRR KKHAVASAAP GQEALVGPSL QPQEAAREAD AVAPGYAQGA NLVKIGERPW RLVRGPGVRA GGPDFLQPSS RESNIRIYSE SAPSWLSKDD IRRMRLLADS AVAGLRPVSS RSGARLLVLE GGAPGAVLRC GPSPCGLLKQ PLDMSEVFAF HLDRILGLNR TLPSVSRKAE FIQDGRPCPI ILWDASLSSA SNDTHSSVKL TWGTYQQLLK QKCWQNGRVP KPESGCTEIH HHEWSKMALF DFLLQIYNRL DTNCCGFRPR KEDACVQNGL RPKCDDQGSA ALAHIIQRKH DPRHLVFIDN KGFFDRSEDN LNFKLLEGIK EFPASAVSVL KSQHLRQKLL QSLFLDKVYW ESQGGRQGIE KLIDVIEHRA KILITYINAH GVKVLPMNE
Explore Golgi-associated kinase 1B with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets